Being Black and pregnant in the deep South can be a dangerous combination

O’laysha Davis was a few weeks shy of her due date when in mid-August she decided it was time to switch doctors.

BridgeBio partners with biomanufacturer Resilience to produce early-stage AAV gene therapies

BridgeBio has tapped biomanufacturing company National Resilience to produce two of its early-phase adeno-associated virus (AAV) gene therapies in a partnership designed to run beyond

October 4, 2023

Avidity to raise $400M; Sato pays Arcutis $25M upfront to license topical roflumilast in Japan

Plus, news about Xencor, Otsuka, Typewriter Therapeutics, Cassava Sciences, Enveric Biosciences, Viking Therapeutics and Janux Therapeutics: Next up in the PIPE bonanza: RNA company Avidity

March 1, 2024

Medicare drug price negotiation didn’t benefit Biden — but it may help Harris

WASHINGTON — When Vice President Kamala Harris takes the stage at the Democratic National Convention next week, she’ll have a fresh policy achievement to tout:

August 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.